PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosgenPLoS GeneticsSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)View this Article
 
PLoS Genet. Aug 2007; 3(8): e134.
Published online Aug 10, 2007. doi:  10.1371/journal.pgen.0030134
PMCID: PMC1941753
A Screen for Suppressors of Gross Chromosomal Rearrangements Identifies a Conserved Role for PLP in Preventing DNA Lesions
Pamela Kanellis,1,2 Mark Gagliardi,1 Judit P Banath,3 Rachel K Szilard,1 Shinichiro Nakada,1 Sarah Galicia,1 Frederic D Sweeney,1,2 Diane C Cabelof,4 Peggy L Olive,3 and Daniel Durocher1,2*
1 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
2 Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Ontario, Canada
3 British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
4 Karmanos Cancer Institute, Detroit, Michigan, United States of America
Orna Cohen-Fix, Editor
National Institute of Diabetes and Digestive and Kidney Diseases, United States of America
* To whom correspondence should be addressed. E-mail: durocher/at/mshri.on.ca
Received February 12, 2007; Accepted June 25, 2007.
Genome instability is a hallmark of cancer cells. One class of genome aberrations prevalent in tumor cells is termed gross chromosomal rearrangements (GCRs). GCRs comprise chromosome translocations, amplifications, inversions, deletion of whole chromosome arms, and interstitial deletions. Here, we report the results of a genome-wide screen in Saccharomyces cerevisiae aimed at identifying novel suppressors of GCR formation. The most potent novel GCR suppressor identified is BUD16, the gene coding for yeast pyridoxal kinase (Pdxk), a key enzyme in the metabolism of pyridoxal 5′ phosphate (PLP), the biologically active form of vitamin B6. We show that Pdxk potently suppresses GCR events by curtailing the appearance of DNA lesions during the cell cycle. We also show that pharmacological inhibition of Pdxk in human cells leads to the production of DSBs and activation of the DNA damage checkpoint. Finally, our evidence suggests that PLP deficiency threatens genome integrity, most likely via its role in dTMP biosynthesis, as Pdxk-deficient cells accumulate uracil in their nuclear DNA and are sensitive to inhibition of ribonucleotide reductase. Since Pdxk links diet to genome stability, our work supports the hypothesis that dietary micronutrients reduce cancer risk by curtailing the accumulation of DNA damage and suggests that micronutrient depletion could be part of a defense mechanism against hyperproliferation.
Cells must ensure the integrity of genetic information before cellular division. Loss of genome integrity is particularly germane to tumorigenesis, where it is thought to contribute to the rapid evolution of the malignant cell towards the fully cancerous phenotype. It is therefore imperative that we understand fully how cells maintain the integrity of the genome and how it is lost during tumorigenesis. In this study, we developed an assay that allowed us to systematically interrogate each gene of the budding yeast S. cerevisiae for its respective contribution to genome integrity. We report the identification of nine novel genes that increase the rate of genome instability in yeast when deleted. To our surprise, one of the genes we identified encodes the enzyme pyridoxal kinase, which acts in the metabolism of vitamin B6. We show that pyridoxal kinase influences genome stability by promoting the conversion of dietary vitamin B6 into its biologically active form, pyridoxal 5′ phosphate. Our work indicates that vitamin B6 metabolites are critical to maintain genome stability and supports a long-standing model, which hypothesizes that vitamin B6 reduces cancer risk by curtailing genome rearrangements.
The faithful replication of the genome is necessary for maintenance of genome integrity. Disrupting processes that ensure faithful DNA replication results in chromosome breakage, hyper-recombination, or gross chromosomal rearrangements (GCRs) [13]. This relationship has been particularly highlighted in the budding yeast S. cerevisiae, where GCRs arise at high rates in cells with defects in the S-phase checkpoint [4], DNA replication licensing [5,6], DNA replication elongation [79], chromatin assembly [10], and homologous recombination (HR) repair [8].
Altogether, these studies not only suggest a common origin (i.e., DNA replication), but also a common mechanism by which genome rearrangements are formed [2]. Defects that occur during DNA replication lead to elevated levels of DNA damage, including DNA double-strand breaks (DSBs). In turn, these lesions may serve as substrates for the illegitimate repair processes resulting in GCRs. Therefore, identification of genes that prevent GCRs can potentially uncover novel genome caretakers that guard cells against the accumulation of mutations. In addition, unbiased identification of GCR suppressors could be a useful route for discovering novel genes and pathways that participate in DNA replication.
Most of the current knowledge regarding GCR formation originates from candidate gene studies examining rearrangements at a single locus in budding yeast, the left arm of Chromosome V (ChrV-L). Although this locus has been instrumental in the deciphering of many basic mechanisms governing genome stability in eukaryotes, examination of GCR formation at other loci provides a complementary view. For example, the use of yeast artificial chromosomes to study GCRs led to the discovery that defective chromosome condensation (in a ycs4 mutant) results in GCR events [7]. In addition, studies employing a Chromosome VII disome found that defects in DNA replication and checkpoint control elevate rates of chromosome loss and rearrangements following replication fork stalling [11]. In another study, Hackett et al. employed the telomeric region of ChrXV-L to study GCR events triggered by telomerase dysfunction [12]. This latter locus is particularly useful since GCRs at ChrXV-L involve break-induced replication (BIR), a type of homologous recombination repair predicted to be a major source of genome rearrangements [2,1315]. In contrast, GCRs formed at ChrV-L are primarily the consequence of de novo telomere addition [8]. This difference can be explained by the architecture of the telomere-proximal region on ChrXV-L, which contains two regions of homology (HRI centered on the PAU20 gene, and HRII centered on the HXT11 gene; Figure 1A) located 12 kb and 25 kb from the telomere [12]. These regions share a high degree of sequence identity with other regions in the genome [12]. As a consequence, DNA lesions formed at loci telomeric to HRI or HRII are predominantly repaired by BIR, producing nonreciprocal translocations in haploid cells. Notably, increased repair by BIR can also lead to loss of heterozygosity in diploid genomes, which may accelerate the process of tumorigenesis by inactivation of tumor suppressor genes.
Figure 1
Figure 1
The ChrXV-L GCR Assay
In this study, we screened the yeast genome for mutants that increase the level of chromosome rearrangements; specifically, those that increase the frequency of BIR-mediated nonreciprocal translocations. We report the construction of a strain containing a GCR reporter on ChrXV-L that is amenable to genome-wide screening and compatible with synthetic genetic array technology [16]. We employed this strain to systematically screen the gene deletion collection [17] leading to the identification of nine new GCR suppressors. Here, we focus on the characterization of one of the most potent GCR suppressors identified, BUD16, which encodes yeast pyridoxal kinase (Pdxk), a critical enzyme in vitamin B6 metabolism. We show that Pdxk is critical for the maintenance of genome integrity via its role in maintaining adequate levels of pyridoxal 5′ phosphate (PLP), the biologically active form of vitamin B6. Our results are consistent with a model whereby dTMP biosynthesis is the pathway affected by a decrease in PLP, thus providing an important link between dietary micronutrients, DNA replication and genome stability. Furthermore, since many epidemiological studies have linked defective vitamin B6 levels to an increased cancer incidence [1823], our study supports the hypothesis that micronutrients such as vitamin B6 curtails carcinogenesis by preventing genomic instability.
A System for the Facile Recovery of BIR-Mediated GCR Events
To generate a GCR reporter strain that is amenable to genome-wide screening, we adapted a system previously described by Hackett et al. [12]. We inserted the CAN1 and URA3 genes, two counter-selectable markers, ~10 kb from the telomere of ChrXV-L (Figure 1A). The simultaneous loss of CAN1 and URA3 (detected on media containing canavinine [can] and 5-fluoro-orotic acid [5-FOA]) at this locus occurs at a rate of 8.9 × 10−8 (Table 1), approximately 250-fold higher than the rate observed at ChrV-L (3.5 × 10−10; Table 2). This elevated GCR rate may be due to the higher efficiency of BIR over de novo telomere addition in repairing DSBs. Moreover, the HRI and HRII regions on ChrXV-L display between 85%–97% homology with a total of 21 chromosome arms [12]. This large number of potential seeds for BIR may also explain the relatively high GCR rate at ChrXV-L. To ensure that the GCR events recovered from the simultaneous loss of CAN1 and URA3 are due to BIR, we analyzed GCR events in wild-type cells by pulsed-field gel electrophoresis (PFGE) using a scheme described by Hackett et al. [12]. Briefly, we isolated genomic DNA from parental canS 5-FOAS cells and cells that have undergone GCR events at ChrXV-L (canR 5-FOAR cells). This DNA is then digested with PmeI to liberate a terminal restriction fragment, separated by PFGE, and finally transferred onto nitrocellulose by Southern blotting to be probed with a ChrXV-L-specific fragment (NOP8; Figure 1B). If BIR occurs by employing any of the 21 homologous chromosome arms as a template, the resulting terminal restriction fragments liberated by PmeI are all predicted to be of lower molecular weight than the parent fragment (~97 kb). As predicted, the analysis of nine canR 5-FOAR mutants derived from the wild-type strain indicate that nine out of nine have undergone a GCR event at ChrXV-L that is consistent with BIR, since their terminal restriction fragments all migrate faster than that of the parental strain (Figure 1B). Furthermore, the analysis of four canR 5-FOAR strains by comparative genome hybridization using tiling microarrays identified breakpoints either in HRI, in the vicinity of the PAU20 gene (in two of four strains analyzed), or in HRII (i.e., in the vicinity of the HXT11 genes, two of four strains; see Figure 1C for two representative examples). Lastly, we determined the GCR rate at ChrXV-L of a rad52Δ strain, since RAD52 is required for BIR. The rad52Δ strain does not produce any detectable GCR events under the standard conditions of our assay (i.e., the rate must be [double less-than sign]8.4 × 10−9; Table 2). This result suggests that most of GCR events observed at ChrXV-L are indeed dependent on RAD52, a gene required for BIR. Collectively, the above results indicate that the ChrXV-L GCR reporter monitors BIR-type events.
Table 1
Table 1
GCR Rates of Mutants Identified from the Genome-Wide GCR Papillation Assay
Table 2
Table 2
ChrXV-L and ChrV-L GCR Rates of Vitamin B6 Mutants
A Genome-Wide Screen for Suppressors of BIR-Mediated GCR Events
We crossed the resulting ChrXV-L GCR assay strain with the 4,812 viable open reading frame deletion strains [16,17] and employed a semi-quantitative papillation assay to monitor GCR formation (Figure S1). An initial set of 48 strains that scored positive were reconstructed in the ChrXV-L assay strain to determine their GCR rate by fluctuation analysis [24] (Table 1). This group included deletions in several known GCR suppressors such as the genes encoding Mre11, a component of the MRX complex, the RecQ helicase Sgs1, and the budding yeast FEN-1 homolog, Rad27. Using this scheme, we identified nine gene deletions that display at least a 10-fold increase in GCR rate compared to wild type (Table 1 and Figure 2A). Of these nine novel GCR suppressors, mutations in RMI1, RAD5, SLX8, and HEX3 were independently reported during the course of this study to promote GCRs at ChrV [2527].
Figure 2
Figure 2
A Genome-Wide Screen Identifies BUD16 as a Key Determinant for Genome Stability in S. cerevisiae
The remaining five novel GCR suppressors include BUD16, WSS1, ESC2, RML2, and ZIP1. Intriguingly, ZIP1 encodes a component of the synaptonemal complex that is active during meiosis [28] and is also expressed in mitotic cells [29], suggesting a potential role for Zip1 in mitotic genome stability. RML2 encodes the mitochondrial L2 ribosomal protein [30]. Surprisingly, a Rml2-GFP fusion protein localizes to the nucleus [31], suggesting a putative nuclear function for Rml2. WSS1 encodes a weak suppressor of an smt3 mutation [32], and ESC2 encodes a protein harboring a SUMO domain that has been linked to heterochromatic silencing [33,34] and the function of the Smc5/6 complex [35]. BLAST searches and alignments reveal that BUD16 encodes a putative Pdxk. With a GCR rate of 1.1 × 10−5 (124-fold above wild type), bud16Δ is within the range of very potent GCR mutator deletions that include rad27Δ (1.3 × 10−5; 148-fold over wild-type rate), mre11Δ (1.3 × 10−5; 140-fold), and sgs1Δ (1.2 × 10−5; 129-fold) (Figure 2A and Table 1). Reintroduction of a plasmid encoding wild-type BUD16 complemented the genome instability of bud16Δ cells, eliminating the possibility that a second site mutation contributes to its elevated GCR rate (Figure 2B). We also examined the type of GCR events promoted by the bud16Δ mutation by PFGE, which indicated that BUD16 prevents BIR-type rearrangements at ChrXV-L (Figure 2C). Given that bud16Δ had the most profound effect on genome stability among the uncharacterized suppressors, we focused on deciphering its role in preventing chromosome rearrangements.
BUD16 Encodes the Yeast Pyridoxal Kinase
In all organisms, Pdxk is an essential component of a vitamin B6 salvage pathway that ultimately produces PLP [36]. To ascertain whether BUD16 functions as the budding yeast Pdxk, we measured PLP levels in wild-type and bud16Δ strains. We found that the PLP levels of bud16Δ cells are only 1.8% of wild-type levels (Table 3). This result is somewhat surprising, since bacteria, yeast, and plants also possess a de novo vitamin B6 pathway that produces PLP in a Pdxk-independent manner. In yeast, this pathway is under the control of the SNO1 and SNZ1 genes [37]. However, these genes are not normally expressed during logarithmic growth but rather are expressed during stationary phase or under poor nutrient conditions. We found that the simultaneous deletion of the SNO1 and SNZ1 locus did not significantly reduce PLP levels (95.2% of wild-type levels; Table 3) or increase GCR rates (Table 2). Although SNO1 and SNZ1 deletion did not significantly impact genome stability (or PLP levels) in BUD16 cells, the de novo vitamin B6 synthetic pathway is nevertheless essential for viability in the absence of BUD16. Indeed, we are unable to recover viable triple mutants from a cross between bud16Δ and sno1snz1Δ or double mutants from a cross between bud16Δ and snz1Δ (Figure 2D). Overall, the decrease in intracellular PLP levels in bud16Δ along with its synthetic lethality with sno1snz1Δ are consistent with the idea that BUD16 functions in parallel with the de novo B6 pathway as a yeast pyridoxal kinase. Additional characterization of the bud16Δ strain in terms of growth and cell cycle kinetics is described in Text S1 and in Figure S2 and Tables S1 and S2.
Table 3
Table 3
Levels of Vitamin B6 (PLP) Measured by HPLC
BUD16 Prevents Genomic Instability at Multiple Genomic Loci
To determine whether the bud16Δ mutation increases genome instability across the genome, we calculated the GCR rate of a bud16Δ strain at the ChrV-L locus [8]. We found that the bud16Δ mutation elevates the GCR rate at this locus 19-fold over the wild-type rate (Figure 3A; Table 2). Analysis of the GCR events involving ChrV by whole-chromosome PFGE reveals a mixture of events consistent with de novo telomere additions (six out of eight events analyzed) and nonreciprocal translocations (two out of eight events) (Figure 3B). This ratio of telomere additions to translocations (4:1) is similar to the ratio of GCRs typically recovered from a wild-type strain [4]. Together, these results indicate that BUD16 suppresses different types of genome rearrangements at a minimum of two different loci in the genome, suggesting that BUD16 may act to prevent the occurrence of DNA lesions rather than by promoting a specific type of illegitimate repair.
Figure 3
Figure 3
Deletion of BUD16 Also Increases GCR Formation at ChrV-L
To further characterize the mechanism that underlies the high GCR rate of bud16Δ cells in the ChrXV-L assay, we crossed the bud16Δ GCR reporter strain to a strain containing a deletion of RAD52, a gene necessary for all types of homologous recombination, including BIR [15]. The GCR rate at ChrXV-L of the bud16Δ rad52Δ double mutant was reduced to wild-type levels (2.4 × 10−8; Table 2). However, this rate is far greater than the GCR rate of a rad52Δ mutation alone (<<8.4 × 10−9; Table 2). Furthermore, analysis of the terminal restriction fragment of the rearranged chromosomes in the bud16Δ rad52Δ double mutant shows terminal deletions in seven out of eight cases that are strikingly larger than those observed in either wild-type or bud16Δ strains (23–37 kb shorter in rad52Δ strains versus ~7–17 kb in the RAD52+ strains; Figure 4A and and4B).4B). This difference in the size of the ChrXV-L terminal restriction fragment suggests that bud16Δ rad52Δ do not undergo BIR-mediated GCR events that employ the HRI/II regions as seeds. Instead, in the absence of functional HR, these mutants are likely repaired by de novo telomere additions, leading to large terminal deletions.
Figure 4
Figure 4
Homologous Recombination Is Required for the BIR-Mediated GCR Events in bud16Δ Cells
Elevated Levels of DNA Lesions and Activation of the DNA Damage Checkpoint in bud16Δ Cells
Together, the observations that BUD16 suppresses GCRs at multiple loci in a BIR-dependent and independent manner suggest that bud16Δ cells experience higher-than-normal levels of DNA lesions during vegetative growth. We find support for this possibility when tetrads from a cross between bud16Δ and rad52Δ are examined (Figure 5A). We observe that the bud16Δ rad52Δ double mutant displays synthetic sickness and poor viability when compared to their congenic single mutants. This result suggests that bud16Δ cells may experience high levels of genotoxic stress that require the HR pathway for optimum viability. Consistent with this explanation, the bud16Δ mutation also displays synthetic sickness when crossed with an MRE11 gene deletion and to a lesser extent with deletion of RAD51, two additional genes acting in the homologous repair of DSBs (Figure 5A). We also observe a strong genetic interaction between the bud16Δ and rad6Δ mutations (Figure 5A), suggesting that DNA lesions caused by the reduction of PLP levels may require post-replicative repair or lesion bypass. Based on this spectrum of genetic interactions, bud16Δ cells likely accumulate DNA lesions during DNA replication, possibly leading to replication fork stalling or collapse.
Figure 5
Figure 5
The BUD16 Gene Deletion Causes DNA Lesions and Checkpoint Activation
To gain more direct evidence for the presence of active RAD52-dependent recombination in bud16Δ cells, we monitored the formation of Rad52 DNA repair centers [38]. Upon formation of lesions that engage HR, Rad52 relocalizes from a diffuse nuclear pattern into discernable punctate foci that coincide with DNA lesions. We thus expressed a Rad52 protein fused to the yellow fluorescent protein (YFP) in wild-type and bud16Δ cells and examined the presence of Rad52 repair centers by fluorescent microscopy (Figure 5B). In bud16Δ cultures, 37%–75% of the cells display Rad52-YFP foci compared to 5%–21% of wild-type cells (Figure 5B). In bud16Δ cultures, Rad52-YFP foci are surprisingly found in G1 (unbudded) cells but are most prevalent in S/G2/M (budded) cells (57%–75% in budded versus 37%–59% in unbudded cells). Intriguingly, the presence of Rad52 foci in G1 nuclei suggests the presence of persistent or unrepairable DNA lesions in cells that have undergone checkpoint adaptation [39]. Furthermore, we observe that budded bud16Δ cells display greater than one repair centre in 12–18% of the cells whereas this situation occurs in less than 2% of wild-type cells (Figure 5C). Since up to ten DSBs may localize to one repair centre [38], these results suggest that bud16Δ cells experience high levels of DNA lesions during DNA replication. Alternatively, we cannot exclude the possibility that bud16Δ cells have a dramatically reduced rate of DNA repair. However, bud16Δ cells are not sensitive to the radiomimetic alkylating agent methyl methanesulfonate (MMS; Figure 5D), indicating that the Rad52 pathway is functional in these cells. Therefore, the increased presence of Rad52 foci in bud16Δ cells is most likely explained by an increased number of DNA lesions.
Next, we examined whether the spontaneous DNA damage present in bud16Δ cells is sufficient to activate the DNA damage checkpoint pathway by assaying Rad53, the yeast homolog of the tumor suppressor Chk2. Rad53 kinase activation is observed by a detectable auto-kinase activity [40] concomitant with a reduced mobility on SDS-PAGE due to autophosphorylation. As shown in Figure 5E, Rad53 is hyperactivated in bud16Δ cells when compared to wild type, indicating that sufficient DNA damage is present in the bud16Δ mutant to activate the DNA damage checkpoint. Phosphorylation of Rad53 in cycling populations is often seen in strains that experience high levels of spontaneous DNA lesions, such as dia2Δ, rrm3Δ, and rmi1Δ, among others [25,41,42]. Altogether, our results are consistent with a model whereby bud16Δ cells experience high levels of DNA lesions, including DSBs. These DNA lesions most likely serve as substrates for illegitimate repair, resulting in elevated levels of genome rearrangements.
Normal PLP Levels Are Required for Genome Integrity
The genome instability observed in the bud16Δ mutant correlates with low levels of PLP. However, this observation does not eliminate the possibility that its GCR mutator phenotype could be due to a PLP-independent function of Bud16/Pdxk. To address this possibility, we aimed to reduce PLP levels by alternative means to probe the relationship between PLP and genome integrity. As a first means, we inactivated other components of the vitamin B6 salvage pathway. In particular, when yeast are grown to log phase under laboratory conditions, the PLP precursor, pyridoxine, is actively transported into cells mainly, but not solely, by the Tpn1 transporter [43]. Therefore, we asked whether TPN1 deletion impacts total PLP levels and genome stability. Cells harboring a tpn1Δ mutation have low levels of intracellular PLP (8% of wild-type; Table 3) that are nevertheless higher than those of bud16Δ. At a genetic level, we find that the tpn1Δ mutation is not synthetic lethal with the sno1snz1Δ double mutant (Figure 6A). The continued viability of the tpn1Δ sno1snz1Δ mutant supports the observation that although Tpn1 is a component of the B6 salvage pathway, it is not absolutely essential for pyridoxine transport [43]. Accordingly, the GCR rate of the tpn1Δ strain at ChrXV-L is increased 47-fold over the wild-type rate, which is less that of the bud16Δ GCR rate (124-fold over wild type; Figure 6B). However, both genes act in the same pathway to suppress genome rearrangements, as the double bud16Δ tpn1Δ mutant display the same GCR rate as bud16Δ (Figure 6B). Lastly, we find multiple Rad52 recombination centers present in 4%–7% of tpn1Δ budded cells, suggesting the presence of catastrophic DNA damage similar to that seen in bud16Δ, albeit at a lower level (Figure 6C). Altogether, these results further suggest that PLP levels correlate with genome integrity.
Figure 6
Figure 6
PLP Levels Correlate with Genome Stability
In addition to manipulating PLP levels via genetic means, we also manipulated pyridoxine intake to further explore the link between PLP levels and genome integrity. To carry out these experiments, we disabled de novo vitamin B6 synthesis (via SNO1 SNZ1 inactivation) to exclude the contribution of this pyridoxine-independent pathway. We also impaired pyridoxine transport by deleting TPN1. When grown in rich media, the resulting tpn1Δ sno1snz1Δ triple mutant has an elevated GCR rate (191-fold over wild type), which is greater than either the tpn1Δ or sno1snz1Δ mutants (Table 2). Accordingly, when we measure the PLP levels of this strain, we find that they are 5.8% of wild-type levels (Table 3). Importantly, we then supplemented the growth media of tpn1Δ sno1snz1Δ with 2 μg/ml pyridoxine as a means to stimulate its transport across the membrane. As shown in Figure 6D and Table 2, addition of pyridoxine to the media of tpn1Δ sno1snz1Δ potently suppresses its GCR rate to wild-type levels. Critically, under the same conditions, the PLP levels of the tpn1Δ sno1snz1Δ strain are dramatically increased to 81.5% of wild type (Figure 6E; Table 3). Together, these data conclusively demonstrate a relationship between PLP levels and maintenance of genome integrity.
Pharmacological Inhibition of Pdxk in Human Cells Causes DNA DSBs
We next examined the role of Pdxk on the genome integrity of human cells by employing the well-characterized vitamin B6 analog 4-deoxypyridoxine (4-DP) [44]. First, we determined whether inhibition of human Pdxk leads to DNA damage, particularly DSBs. To detect DSBs in human cells, we examined the localization of 53BP1, a DNA repair and signaling protein, by immunofluorescence microscopy. 53BP1 forms nuclear foci that colocalize with DSBs in mammalian cells and is thus a useful surrogate marker of this type of DNA damage [45]. As shown in Figure 7A and and7B,7B, addition of 4-DP to the media of HeLa cells causes an accumulation of 53BP1 foci. Second, we found that 4-DP treatment also triggers activation of the checkpoint kinase Chk2, as evidenced by phosphorylation of its Thr68 residue (Figure 7C). Third, we analyzed the phosphorylation status of H2AX on its C-terminal Ser139 residue (known as γ-H2AX), one of the earliest events in the response to DSBs. The presence of γ-H2AX was assessed via immunoblotting (Figure 7C) and flow cytometry (Figure 7D) [46]. In cells treated with the Pdxk inhibitor 4-DP, γ-H2AX clearly accumulates during S-phase between the 2N and 4N DNA content, similar to what is observed in yeast cells (with Rad52-YFP). Importantly, to ensure that the described effects were not due to apoptotic effects caused by Pdxk inhibition at the concentrations of 4-DP employed above, we measured levels of apoptosis in HeLa cells by annexin V staining (Figure S3). From this data, we can rule out the possibility that 4-DP triggers DSB formation via the activation of an apoptotic program. Instead, our results indicate that, as in yeast cells, Pdxk inhibition induces DNA lesions and activation of the DNA damage response.
Figure 7
Figure 7
Inhibition of Pdxk Causes DSBs in Human Cells
PLP May Affect dTMP Biosynthesis to Impact Genome Stability
We finally sought to narrow down the biological pathway in which PLP acts to promote genome stability. This is a difficult task, since PLP is a critical cofactor for numerous essential enzymes acting in amino acid and dTMP biosynthesis. However, our observations in yeast and human cells indicate a role for PLP in preventing DNA lesions during DNA replication, pointing to dTMP synthesis as the likeliest candidate pathway linking PLP to genome stability (Figure 8A). This possible association is strengthened by the multitude of observations that link dTMP biosynthesis to genome integrity in both prokaryotes and eukaryotes (reviewed in [47]). In this context, PLP deficiency may either cause aberrant uracil incorporation into DNA, generate a nucleotide imbalance that impairs DNA replication fork stability, or both. We therefore sought to assess the involvement of PLP in dTMP biosynthesis by testing whether bud16Δ cells accumulate uracil nucleotides in their DNA. To do so, we employed a recently described modified aldehydic slot blot assay that detects abasic sites produced when isolated DNA is treated with a uracil glycosylase enzyme [48]. As shown in Figure 8B, strains lacking Pdxk (bud16Δ) accumulate uracil in their genome significantly more than their wild-type counterparts. This accumulation is likely to be biologically important, as it is in the same range as the uracil accumulation observed in cells deficient in uracil glycosylase (ung1Δ cells), the main enzyme dedicated to the removal of uracil in DNA (Figure 8C). Furthermore, the double ung1Δ bud16Δ mutant accumulates more uracil in its genome than either of the single mutants, suggesting that UNG1 and BUD16 function in separate pathways to prevent uracil incorporation into DNA. These results are therefore consistent with a model in which the bud16Δ mutation increases dUMP pools, thereby increasing the frequency of dUTP incorporation into DNA.
Figure 8
Figure 8
PLP levels Are Required for Optimal dTMP Biosynthesis
Accumulation of uracil in genomic DNA may lead to DSB accumulation and attendant genome instability via excision of uracil and production of excessive abasic sites. However, deletion of UNG1 does not suppress the bud16Δ genome instability rate and in fact results in a GCR rate increase (Table 2). This result indicates that either uracil excision is not a major cause of DNA damage in cells with low PLP levels, that an alternative excision pathway is involved, or that it is the accumulation of uracil that poses a threat to replication fork progression. Alternatively, it is also possible that a nucleotide pool imbalance caused by dUTP accumulation is a source of replication stress in bud16Δ cells. If bud16Δ cells have a defect in maintaining nucleotide pools, they may display some form of sensitivity to hydroxyurea (HU) a ribonucleotide reductase inhibitor. As shown in Figure 8D, HU dramatically affects the growth of bud16Δ cells at all concentrations tested and also leads to inviability of bud16Δ at 0.2 M HU, as measured by a colony-forming assay (Table S3). In contrast and as discussed above, bud16Δ cells are resistant to MMS, a DNA alkylating agent that causes DNA replication stress by impeding replication fork progression [49] (Figure 5D). Therefore, bud16Δ cells are sensitive to the depletion of deoxyribonucleotides rather than to replication stress. From these results, we suggest that PLP deficiency triggers DNA lesions due to a nucleotide imbalance resulting from defects in dTMP biosynthesis.
A Genome-Wide Screen for Suppressors of Chromosome Rearrangements at ChrXV-L
In this report, we describe a screen for suppressors of rearrangements at ChrXV-L, a locus producing chromosome aberrations primarily via BIR. Since this locus is different from the commonly used ChrV-L locus, we expected overlapping and distinct sets of genes with those already known to prevent rearrangements of ChrV. Indeed, comparison of the results of our screen with a similar screen undertaken using the ChrV-L reporter chromosome [50] identifies only two overlapping GCR suppressor genes, RAD5 and MRE11. This lack of overlap between both screens indicates that neither screen was saturating or that both loci can identify distinct classes of genome stability regulators. Indeed, we observed that disruption of some genes (such as SGS1) potently affects the GCR rate at the ChrXV-L locus while having a much more modest effect at ChrV [51], indicating that some genes may specifically suppress BIR.
In addition to Pdxk (Bud16), most of the other genes identified in our screen are likely to prevent DNA replication stress, suggesting that an unbiased screen for GCR suppressors is a potentially fruitful means of discovering novel activities influencing DNA replication. In particular, deletion of WSS1, which encodes a potential protease acting in the SUMO pathway [52], is synthetic lethal with deletion of SGS1, the yeast RecQ homolog [53]. This result, coupled with the high GCR rate of the wss1Δ strain, suggests that Wss1, perhaps via its proteolytic activity, acts in the management of DNA replication forks to prevent their demise. Likewise, Esc2 likely participates in maintaining replication fork integrity and tolerance to replication stress, given the ascribed role of its fission yeast homolog Rad60 in these processes [35,54]. Perhaps more puzzling is our identification of ZIP1, a meiotic gene, and RML2, encoding a mitochrondrial ribosome component, as GCR suppressors. Therefore, this study revealed several novel GCR regulators, which may be part of several less well-understood GCR suppression pathways. It will be important to decipher whether the products of these genes do indeed participate in the maintenance of mitotic genome integrity.
Yeast as a System to Study the Influence of Micronutrients on Genome Stability
The link between decreased intracellular PLP levels and genome stability is important, since vitamin B6 deficiency correlates with heightened cancer risk [1823]. This work therefore provides support for a model whereby subnormal levels of vitamin B6 may promote cancer development by engendering DNA lesions and attendant genome rearrangements. Given the poorly understood link between diet and cancer incidence, the ChrXV-L GCR assay provides a simple genetic system to probe the consequences of micronutrient deficiency on genome stability. Although the potential link between vitamin B6 and chromosome breakage had been suggested previously [20], the lack of a genetically tractable system to study the role of micronutrients in genome integrity has prevented a definitive mechanistic explanation of the vitamin B6–cancer epidemiological link. This situation has led to a multitude of alternative explanations. For example, other groups have contended that PLP decreases cellular proliferation or protects cells from oxidative stress [55,56]. We directly tested the possibility that reactive oxygen species affect the GCR rate of bud16Δ cells by growing them in the presence of the reactive oxygen species scavenger N-acetylcysteine (NAC). To our surprise, treatment with this compound increased rather than decreased the bud16Δ GCR rate (Table 2), indicating that reactive oxygen species may not play a major role in the formation of genome rearrangements when PLP levels are low.
A Physiological Role for Intracellular Micronutrient Depletion?
Replication stress is thought to be a major deleterious event, as it is a source of DNA lesions and genome rearrangements. Paradoxically, recent observations point to a beneficial role for replication stress as an innate defense mechanism against tumorigenesis. Indeed, replication stress appears to be a hallmark of precancerous and hyperproliferating cells [57,58]. In this context, replication stress leads to activation of a DNA damage response that initiates senescence, thereby stopping the growth of a potential tumor [5761]. These observations suggest that cells are wired to produce DNA lesions when their proliferation is aberrantly stimulated. One key and unresolved question that emerges from this body of work pertains to the nature of the cellular processes that trigger replication stress in response to uncontrolled cell growth. We speculate that our work, which links depletion of PLP to replication-associated DNA lesions, provides a simple mechanism that could link hyperproliferation to the activation of the DNA damage response. Indeed, we hypothesize that the exhaustion of metabolites through unscheduled anabolic processes may be primarily sensed as DNA replication stress. It will therefore be interesting to see whether intracellular PLP levels are decreased in precancerous lesions or whether Pdxk inhibition can sensitize cells to oncogene-induced cellular senescence.
Plasmid construction.
The CAN1 gene from strain BY4741 was amplified from genomic DNA and cloned next to the URA3MX gene marker in the BglII site of pAG60 [62] to yield DDp418. To construct pBUD16 (DDp626), the BUD16 locus encompassing the BUD16 open reading frame was amplified by PCR from yeast genomic DNA and cloned in pCR2.1-TOPO (Invitrogen, http://www.invitrogen.com) and sequenced. The BUD16 locus was then excised with SpeI and NotI and cloned into the SpeI and NotI sites of pRS415.
Strain construction.
To construct the GCR assay strain (DDY643) the CAN1 gene of BY4741 strain was replaced with the MFA1pr-HIS3 marker [16]. This strain was then transformed with a PCR fragment containing the cycloheximide-resistance cyh2 marker to yield strain DDY642. The CAN1-URA3 cassette was amplified from DDp418 with primers CAN1-URA3 F1: 5′-GAA TCT GCC GTT TCG ATT TAC TTC GAT AAA GTT TGC GTT GTG AGT CAT ACG GCT TTT TTG-3′ and CAN1-URA3 JM R1: 5′-GGA AAA TTC TGG TCT ATT CAC AAT GAC AAG CGG TGA GCG TGT ATA GCG ACC AGC ATT CAC-3′ (underlined regions anneal to DDp418 and flanking regions are homologous to ChrXV-L). A second round of PCR with the following primers extended homology to the ChrXV-L region: CAN1-URA3 F2: 5′-TAT TGT GAA TTG AAA TTT AAA GTT ATC TCA AAT TCA AAT GAA TCT GCC GTT TCG ATT TAC-3′ and CAN1-URA3 R2: 5′-AGA TGG CTT TTC CAT CAG AGC CAT TGT GAA GAA ATC GGA GGA AAA TTG TGG TCT ATT CAC-3′ (underlined regions anneal to the PCR product from the first round). This amplified fragment was introduced in DDY642 to yield DDY643 and was verified by PCR analysis. The MATα strain (DDY644) used in the screen was derived from DDY643 by mating type switching. All other strains were generated using genetic crosses, via one-step disruptions or via transformation of the indicated plasmids (see Table 4 for genotypes).
Table 4
Table 4
Yeast Strains Used in This Study
Screening procedure.
To generate gene deletions in the ChrXV-L GCR assay strain, we employed synthetic genetic array technology, essentially as described by Tong et al. [16]. Briefly, DDY644 was mated to the MATa deletion strains from EUROSCARF (http://web.uni-frankfurt.de/fb15/mikro/euroscarf/) on YPD and incubated at 30 °C overnight. Diploids were selected on SD-URA + 200 mg/L G418 and incubated at 30 °C for 2 d. Sporulation proceeded on YE + 0.05% glucose for 7 d at 25 °C. Once sporulated, haploids were selected by a four-step pinning procedure: two selections on SD-URA-HIS + cycloheximide (10 mg/L) followed by two selections on SD-URA-HIS + cycloheximide (10 mg/L) + G418 (200 mg/L). Following the fourth selection step, each deletion mutant was hand patched onto nonselective rich XY media (2% peptone, 1% yeast extract, 0.01% adenine, and 0.02% tryptophan). Fourteen mutants in duplicate were patched onto a single 10-cm plate. They were allowed to grow for 2 d at 30 °C and were then replica plated onto agar plates to remove excess cells prior to replica plating onto FC (5-FOA and can) media. FC plates were incubated for 3 d at 30 °C following replica plating and analyzed for colony formation. Wild-type strains produced between 0–3 colonies on average. Therefore, we scored a patch as a positive hit if the threshold number of colonies per patch were equal to or greater than ten. Deletion mutants (1,160) were then placed in a “1 hit” category (for those with one patch that displayed greater than ten colonies) or were in a “2 hit” category (for those with both patches that showed greater than ten colonies). The “2 hit” category list, which consisted of 273 mutants, was narrowed down by focusing on genes that are expressed in the nucleus [31]. However, we did not discard any gene deletion that had unknown localization data. These filters reduced the number of positive hits to 125. Of these 125, we reconstructed 48 deletions in the DDY643 background. Once constructed and confirmed, these mutants were frozen at −80 °C immediately in SC-URA to ensure retention of the CAN1-URA3 markers.
Measurement of GCRs.
Strains were grown in SC-URA media to select for the URA3-CAN1 ChrXV-L arm prior to streaking cells onto nonselective rich media (XY). Single colonies were isolated and grown in 5 ml of XY medium until saturation. For wild-type strains, 1 ml of culture was spun down and plated onto a 10-cm FC plate and the number of cells/ml was calculated. A fluctutation test and the method of the median [24] was used to assess GCR rate. Similarily, for the ChrV-L GCR assay, a single colony was inoculated into 15 ml of XY medium until saturation. These cells were spun down and plated onto a 15-cm FC plate and the number of cells/ml was calculated. Again, a fluctuation test and the method of the median were used to measure GCR rates. To assess the effects of pyridoxine supplementation on genome stability, cells were grown in the absence or presence of 2 μg/ml pyridoxine hydrochloride (Supelco; http://www.sigmaaldrich.com/).
Measurement of PLP by HPLC.
Wild-type, bud16Δ, tpn1Δ, sno1snz1Δ, and tpn1Δ sno1snz1Δ strains were grown in 100-ml cultures of XY + 2% glucose (with the exception of tpn1Δ sno1snz1Δ) to early log phase (OD600 1.0). The cells were spun down and washed thrice with 50 ml of cold double-distilled water to remove any external PLP. Cells were then pelleted and lysed by glass beads in 5% TCA. Lysates were clarified by centrifugation at high speed to remove cell debris. PLP measurements were done blindly at the diagnostic division of Anticancer (http://www.anticancer.com/).
Rad52-YFP fluorescent microscopy.
We assessed Rad52-YFP focus formation assay essentially as described by Lisby et al. [38] with the following modifications. Three independent isolates of each strain containing the pRAD52-YFP plasmid (a gift of Grant Brown) were grown in SC-LEU. Cells were imaged on an Nikon Eclipse E600 FN microscope (http://www.nikonusa.com) equipped with an ORCA ER2 camera (http://www.hamamatsu.com) and Chroma filters (http://www.chroma.com/). Micrographs were taken in 21 z-stacks with 0.007-μm increments. For each independent isolate, a minimum of 180 cells were examined.
Mammalian cell culture.
HeLa cells were grown in DMEM supplemented with 10% fetal calf serum. SiHa cervical carcinoma cells were obtained from the American Type Culture Collectin (http://www.atcc.org) and maintained in exponential growth by twice-weekly subcultivation in minimal essential medium containing 10% fetal bovine serum (Gibco, http://www.invitrogen.com/). A stock solution of 4-DP (200 mM) was prepared in 0.9% saline, diluted in growth medium, and adjusted to pH 7.2.
Western blotting and kinase assays.
Human whole-cell extracts (25 μg) were prepared by boiling the cellular pellet in 1× SDS sample buffer for 5 min. Extracts were loaded onto an SDS-PAGE gel and after electrophoresis, proteins were transferred to a PVDF membrane (Millipore, http://www.millipore.com/) and immunoblotted with either the phospho-Chk2(Thr68) or Chk2 primary antibodies (Cell Signaling Technology, http://www.cellsignal.com/) followed by horseradish peroxidase-coupled secondary antibody (Jackson ImmunoResearch Laboratories, http://www.jacksonimmuno.com/). Rad53 immunoblotting and autokinase assays were carried out on denatured cell extracts exactly as described previously [9,63].
Immunofluorescence.
HeLa cells grown on coverslips were washed twice in PBS and fixed with 2% PFA for 1 h at room temperature, washed, and permeabilized with 1% Triton-X in PBS (1h, room temperature) and subsequently blocked for an additional 1 h in 10% antibody dilution buffer (10% normal goat serum, 3% BSA, and 0.05% Triton X in PBS). Monoclonal 53BP1 antibody (Transduction Laboratories) was diluted in blocking buffer and incubated with cells overnight at room temperature followed by two 10 min washes in 0.05% Triton X-100 in PBS. The appropriate Alexa-555 conjugated secondary antibody (Molecular Probes, http://probes.invitrogen.com/) was diluted 1:500 in 10% antibody dilution buffer and incubated with the coverslips for 2 h at room temperature. After several washes with PBS, the cells were stained with DAPI (10 μg/ml) for 20 min and mounted with ProLong Gold anti-fade agent (Molecular Probes).
Pulse-field gel electrophoresis.
Briefly, ~1 × 108 cells grown from a saturated culture were spun down, washed, and then resuspended in TE (pH 7.5) and Zymolyase (Zymo Research, http://www.zymoresearch.com. Plugs were formed by mixing liquefied low melt agarose (SeaKem; http://www.lonza.com) with the resuspended cells and solidified in plug molds. Plugs were transferred into LET solution (0.5M EDTA pH 8.0, 0.01M Tris-HCl (pH 7.5), 40mM DTT, and 0.4mg/ml Zymolyase) overnight at 37 °C. Plugs were then transferred into fresh tubes containing NDS solution (0.5 M EDTA pH 9.5, 0.01 M Tris-HCl pH 7.5, 1% N-lauroyl sarcosine sodium salt, and 2 mg/ml proteinase K) and incubated at 50 °C overnight. Plugs were washed several times in TE (pH 7.5) and incubated for 1 h. Plugs containing whole chromosomes were immediately run on a CHEF-DR III system (Bio-Rad, http://www.bio-rad.com/) using a 1% agarose gel and 0.5× TBE at 14 °C, switch time 6–120 s, angle 120° for 24 h with a voltage gradient of 6V/cm. To examine the size of the terminal restriction fragment on ChrXV-L, whole chromosomes were prepared as described above in agarose plugs and were then digested with the restriction enzyme PmeI. Plugs of digested chromosomes were run on a 1% agarose gel in 0.5× TBE at 14 °C, switch time 1–15 s, angle 120°, 19 h with a voltage gradient of 6V/cm.
Flow cytometry and cell size.
SiHa cells (5 × 105) were fixed in 1.4 ml of 70% ethanol and kept at −20° C for up to two weeks before analysis. All fixed samples were prepared for antibody staining and analyzed on the same day. One milliliter of cold Tris-buffered saline, pH 7.4 (TBS) was added to each tube, then the cells were spun down and resuspended in 1 ml of cold 4% FBS and 0.1% Triton X-100 (TST) and placed on ice. Cells were allowed to rehydrate for 10 min, then spun down and resuspended in 200 μl of mouse monoclonal anti-phospho-histone H2A.X antibody (Upstate Biotechnology http://www.millipore.com/), which was diluted 1:500 in TST. Tubes were incubated on a shaker for 2 h at room temperature, rinsed with cold TST, and resuspended in 200 ul of secondary antibody (Alexa 488 goat antimouse IgG [H + L]F[ab′]2 fragment conjugate [Molecular Probes] diluted 1:200 in TST) for 1 h at room temperature. Cells were rinsed in 2% FBS in TBS and resuspended in 400 μl of cold TBS containing 1 μg/ml DAPI. Samples were analyzed using a Coulter Elite dual laser flow cytometer (http://www.beckmancoulter.com). List mode files were analyzed using WinList software (Verity Software House, http://www.vsh.com/).
Uracil detection.
DNA was isolated from yeast strains using Qiagen (http://www.qiagen.com) gravity tip columns as per the manufacturer's protocol and assayed for uracil incorporation as described in Cabelof et al. [64]. Briefly, 4 μg of DNA was blocked for 2 h at 37 °C in a 2× tris/methoxyamine buffer (final concentration: 100 mM methoxyamine [Sigma-Aldrich, http://www.sigmaaldrich.com/] and 50 mM Tris-HCl, pH 7.4). DNA was precipitated with 7.5% volumes of 4 M NaCl and 4 volumes of ice-cold 100% ethanol and resuspended in TE buffer, pH 7.6. DNA was then treated with 0.4 units of Uracil DNA Glycosylase (New England Biolabs, http://www.neb.com) for 15 min at 37 °C, immediately precipitated, and resuspended in TE buffer, pH 7.6. DNA was then probed with 2 mM aldehydic reactive probe (Dojindo Molecular Technology, http://dojindo.com/) for 15 min at 37 °C followed by ethanol precipitation and resuspension in TE buffer, pH 7.6. DNA was then heat denatured, immobilized onto a nitrocellulose membrane (Schleicher and Schuell, http://www.whatman.com/), and baked under vacuum as originally described by Nakamura et al. [48]. The dried membrane was washed in 5× SSC for 15 min at 37 °C, then incubated in a prehybridization buffer (20 mM Tris, pH 7.5; 0.1 M NaCl; 1 mM EDTA; 0.5% casein w/v; 0.25%BSA w/v; and 0.1% Tween-20 v/v) for 30 min at room temperature. Streptavidin-POD conjugate (Roche, http://www.roche.com/) was added at a 1:2,000 dilution for 45 min at room temperature. Membrane was washed in TBS/Tween-20 three times at 37 °C, incubated in ECL solution (Pierce, http://www.piercenet.com/) for 5 min at room temperature, then visualized and quantified using a ChemiImagerTM system (Alpha Innotech, http://www.alphainnotech.com/). Data are expressed as the integrated density value of the band per microgram of DNA loaded on the membrane.
Comparative genome hybridization.
Yeast genomic DNA was prepared from saturated 10-ml cultures essentially by the method of [65]. Genomic DNA (2 μg) was digested for 2 h with 10 U of HaeIII and purified by phenol-chloroform extraction and ethanol precipitation. HaeIII-digested genomic DNA (50 μg) was labeled and hybridized by the method of [66]. Briefly, after blunting the DNA ends with T4 polymerase, the fragments were ligated to unidirectional linkers and amplified by ligation-mediated PCR in the presence of aminoallyl-modified dUTP. Indirect labeling was performed using monoreactive Cy5 (for the parental strain) or Cy3 (strains that had undergone GCR) NHS esters that react specifically with the aminoallyl-dUTP. Control and experimental samples were combined, and the labeled DNA was hybridized to a yeast whole-genome ChIP-on-chip microarray (4 × 44K; Agilent Technologies, http://www.home.agilent.com/) and scanned at the University Health Network Microarray Centre (http://www.microarrays.ca/). Microarray images were processed with GenePix Pro 6.0 (Molecular Devices, http://www.moleculardevices.com). Data were analysed as described previously [67]. Hybridization data were preprocessed with ArrayPipe 1.7 [68], the background was subtracted using the “foreground-background” correction method, the data were normalized using the “linear model for microarray analysis (limma) loess (subgrid) method,” and the results were mapped using the University of California Santa Cruz genome browser (http://genome.ucsc.edu/cgi-bin/hgGateway).
Text S2 contains supplementary materials and methods for apoptosis analysis, yeast DNA content, and cell size distributions.
Figure S1: A Semi-Quantitative Papillation-Based Assay to Estimate GCR Rates
(6.5 MB PDF)
Figure S2: Cell Cycle Progression and Cell Size Phenotypes of bud16Δ
(439 KB PDF)
Figure S3: 4-DP Does Not Trigger Apoptosis
(479 KB PDF)
Table S1: Growth Rate of Vitamin B6 Mutants
(31 KB DOC)
Table S2: Mean and Median Cell Size of bud16Δ and tpn1Δ Mutants
(32 KB DOC)
Table S3: Cell Viability and Growth Rate of bud16Δ Mutants Grown in HU and MMS
(38 KB DOC)
Text S1: Supplementary Results
Phenotypic characterization of the bud16Δ mutant.
(39 KB DOC)
Text S2: Supplementary Materials and Methods
Apoptosis analysis, yeast DNA content, and cell size distributions.
(33 KB DOC)
Acknowledgments
We thank the members of the Durocher laboratory for their help and discussions. We especially thank Mike Downey and David Lydall for critically reading the manuscript. We also thank Kyungjae Myung, Richard Kolodner, Rodney Rothstein, Grant Brown, Mike Tyers, and Margaret Werner-Washburne for the gift of strains and plasmids and François Robert for the use of his microarray LIMS system.
Abbreviations
BIRbreak-induced replication
cancanavinine
ChrV-L,left arm of Chromosome V
DSBdouble-strand breaks
4-DP4-deoxypyridoxine
FC5-fluoro-orotic acid and canavinine; 5-fluoro-orotic acid
GCRgross chromosomal rearrangement
HRhomologous recombination
HUhydroxyurea
MMSmethyl methanesulfonate
NACN-acetylcysteine
Pdxkpyridoxal kinase
PFGEpulsed-field gel electrophoresis
PLPpyridoxal 5′ phosphate
YFPyellow fluorescent protein

Footnotes
Author contributions. PK and DD conceived and designed the experiments, except for the FACS analysis of γ-H2AX, which was designed by PLO, and uracil quantitation, which was designed with DCC. PK performed all the yeast-related experiments except for the examination of Rad53 activity, which was done with the help of FDS. MG examined the formation of 53BP1 foci in response to 4-DP and examined the activation of the checkpoint response by Western blotting. JB quantitated γ-H2AX formation by flow cytometry. RKS mapped the breakpoints by CGH. SN examined the levels of apoptosis in response to 4-DP. SG performed some of the GCR assays. DCC determined uracil content in genomic DNA. PK and DD wrote the paper with valued input from RKS, DCC, and PLO.
Funding. PK and FDS hold Terry Fox Studentships from National Cancer Institute of Canada. SN holds a Gail Posluns Fellowship in Hematology. DD is the Canada Research Chair (tier II) in Proteomics, Bioinformatics and Functional Genomics. This work was funded by grants from the National Cancer Institute of Canada with funds from the Candian Cancer Society (to PLO and DD) and National Institutes of Health grant 1F32-ES013643 (to DCC).
Competing interests. The authors have declared that no competing interests exist.
  • McGlynn P, Lloyd RG. Recombinational repair and restart of damaged replication forks. Nat Rev Mol Cell Biol. 2002;3:859–870. [PubMed]
  • Kolodner RD, Putnam CD, Myung K. Maintenance of genome stability in Saccharomyces cerevisiae. Science. 2002;297:552–557. [PubMed]
  • Casper AM, Nghiem P, Arlt MF, Glover TW. ATR regulates fragile site stability. Cell. 2002;111:779–789. [PubMed]
  • Myung K, Datta A, Kolodner RD. Suppression of spontaneous chromosomal rearrangements by S phase checkpoint functions in Saccharomyces cerevisiae. Cell. 2001;104:397–408. [PubMed]
  • Lengronne A, Schwob E. The yeast CDK inhibitor Sic1 prevents genomic instability by promoting replication origin licensing in late G(1) Mol Cell. 2002;9:1067–1078. [PubMed]
  • Tanaka S, Diffley JF. Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation. Genes Dev. 2002;16:2639–2649. [PubMed]
  • Huang D, Koshland D. Chromosome integrity in Saccharomyces cerevisiae: the interplay of DNA replication initiation factors, elongation factors, and origins. Genes Dev. 2003;17:1741–1754. [PubMed]
  • Chen C, Kolodner RD. Gross chromosomal rearrangements in Saccharomyces cerevisiae replication and recombination defective mutants. Nat Genet. 1999;23:81–85. [PubMed]
  • Kanellis P, Agyei R, Durocher D. Elg1 forms an alternative PCNA-interacting RFC complex required to maintain genome stability. Curr Biol. 2003;13:1583–1595. [PubMed]
  • Myung K, Pennaneach V, Kats ES, Kolodner RD. Saccharomyces cerevisiae chromatin-assembly factors that act during DNA replication function in the maintenance of genome stability. Proc Natl Acad Sci U S A. 2003;100:6640–6645. [PubMed]
  • Admire A, Shanks L, Danzl N, Wang M, Weier U, et al. Cycles of chromosome instability are associated with a fragile site and are increased by defects in DNA replication and checkpoint controls in yeast. Genes Dev. 2006;20:159–173. [PubMed]
  • Hackett JA, Feldser DM, Greider CW. Telomere dysfunction increases mutation rate and genomic instability. Cell. 2001;106:275–286. [PubMed]
  • Smith CE, Llorente B, Symington LS. Template switching during break-induced replication. Nature. 2007;447:102–105. [PubMed]
  • Haber JE. DNA recombination: The replication connection. Trends Biochem Sci. 1999;24:271–275. [PubMed]
  • Malkova A, Ivanov EL, Haber JE. Double-strand break repair in the absence of RAD51 in yeast: A possible role for break-induced DNA replication. Proc Natl Acad Sci U S A. 1996;93:7131–7136. [PubMed]
  • Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, et al. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 2001;294:2364–2368. [PubMed]
  • Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999;285:901–906. [PubMed]
  • Zhang SM, Moore SC, Lin J, Cook NR, Manson JE, et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2006;163:108–115. [PMC free article] [PubMed]
  • Vitamin B6 may help prevent colorectal cancer in women. A dietary component is poised to join a list of strategies that help lower our risk for this largely preventable cancer. Harv Womens Health Watch. 2005;12:1–2. [PubMed]
  • Ames BN, Wakimoto P. Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer. 2002;2:694–704. [PubMed]
  • Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76:678–687. [PMC free article] [PubMed]
  • Hartman TJ, Woodson K, Stolzenberg-Solomon R, Virtamo J, Selhub J, et al. Association of the B-vitamins pyridoxal 5′-phosphate (B(6)), B(12), and folate with lung cancer risk in older men. Am J Epidemiol. 2001;153:688–694. [PubMed]
  • Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, et al. Colorectal adenomas and the C677T MTHFR polymorphism: Evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev. 1999;8:659–668. [PubMed]
  • Lea DE, Coulson CA. The distribution of the numbers of mutants in bacterial populations. J Genet. 1948;49:264–285. [PubMed]
  • Chang M, Bellaoui M, Zhang C, Desai R, Morozov P, et al. RMI1/NCE4, a suppressor of genome instability, encodes a member of the RecQ helicase/Topo III complex. EMBO J. 2005;24:2024–2033. [PubMed]
  • Huang ME, Rio AG, Nicolas A, Kolodner RD. A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations. Proc Natl Acad Sci U S A. 2003;100:11529–11534. [PubMed]
  • Zhang C, Roberts TM, Yang J, Desai R, Brown GW. Suppression of genomic instability by SLX5 and SLX8 in Saccharomyces cerevisiae. DNA Repair (Amst) 2006;5:336–346. [PubMed]
  • Sym M, Engebrecht JA, Roeder GS. ZIP1 is a synaptonemal complex protein required for meiotic chromosome synapsis. Cell. 1993;72:365–378. [PubMed]
  • Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, et al. Global analysis of protein expression in yeast. Nature. 2003;425:737–741. [PubMed]
  • Pan C, Mason TL. Functional analysis of ribosomal protein L2 in yeast mitochondria. J Biol Chem. 1997;272:8165–8171. [PubMed]
  • Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, et al. Global analysis of protein localization in budding yeast. Nature. 2003;425:686–691. [PubMed]
  • Biggins S, Bhalla N, Chang A, Smith DL, Murray AW. Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. Genetics. 2001;159:453–470. [PubMed]
  • Cuperus G, Shore D. Restoration of silencing in Saccharomyces cerevisiae by tethering of a novel Sir2-interacting protein, Esc8. Genetics. 2002;162:633–645. [PubMed]
  • Dhillon N, Kamakaka RT. A histone variant, Htz1p, and a Sir1p-like protein, Esc2p, mediate silencing at HMR. Mol Cell. 2000;6:769–780. [PubMed]
  • Boddy MN, Shanahan P, McDonald WH, Lopez-Girona A, Noguchi E, et al. Replication checkpoint kinase Cds1 regulates recombinational repair protein Rad60. Mol Cell Biol. 2003;23:5939–5946. [PMC free article] [PubMed]
  • McCormick DB, Chen H. Update on interconversions of vitamin B-6 with its coenzyme. J Nutr. 1999;129:325–327. [PubMed]
  • Rodriguez-Navarro S, Llorente B, Rodriguez-Manzaneque MT, Ramne A, Uber G, et al. Functional analysis of yeast gene families involved in metabolism of vitamins B1 and B6. Yeast. 2002;19:1261–1276. [PubMed]
  • Lisby M, Rothstein R, Mortensen UH. Rad52 forms DNA repair and recombination centers during S phase. Proc Natl Acad Sci U S A. 2001;98:8276–8282. [PubMed]
  • Lettier G, Feng Q, de Mayolo AA, Erdeniz N, Reid RJ, et al. The role of DNA double-strand breaks in spontaneous homologous recombination in S. cerevisiae. PLoS Genet. 2006. e194. doi: 10.1371/journal.pgen.0020194. [PMC free article] [PubMed]
  • Pellicioli A, Lucca C, Liberi G, Marini F, Lopes M, et al. Activation of Rad53 kinase in response to DNA damage and its effect in modulating phosphorylation of the lagging strand DNA polymerase. EMBO J. 1999;18:6561–6572. [PubMed]
  • Blake D, Luke B, Kanellis P, Jorgensen P, Goh T, et al. The F-box protein Dia2 overcomes replication impedance to promote genome stability in Saccharomyces cerevisiae. Genetics. 2006;174:1709–1727. [PubMed]
  • Ivessa AS, Lenzmeier BA, Bessler JB, Goudsouzian LK, Schnakenberg SL, et al. The Saccharomyces cerevisiae helicase Rrm3p facilitates replication past nonhistone protein-DNA complexes. Mol Cell. 2003;12:1525–1536. [PubMed]
  • Stolz J, Vielreicher M. Tpn1p, the plasma membrane vitamin B6 transporter of Saccharomyces cerevisiae. J Biol Chem. 2003;278:18990–18996. [PubMed]
  • Mizuno N, Kawakami K, Morita E. Competitive inhibition between 4′-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain. J Nutr Sci Vitaminol (Tokyo) 1980;26:535–543. [PubMed]
  • Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol. 2000;151:1381–1390. [PMC free article] [PubMed]
  • Olive PL. Detection of DNA damage in individual cells by analysis of histone H2AX phosphorylation. Methods Cell Biol. 2004;75:355–373. [PubMed]
  • Ahmad SI, Kirk SH, Eisenstark A. Thymine metabolism and thymineless death in prokaryotes and eukaryotes. Annu Rev Microbiol. 1998;52:591–625. [PubMed]
  • Nakamura J, Walker VE, Upton PB, Chiang SY, Kow YW, et al. Highly sensitive apurinic/apyrimidinic site assay can detect spontaneous and chemically induced depurination under physiological conditions. Cancer Res. 1998;58:222–225. [PubMed]
  • Tercero JA, Longhese MP, Diffley JF. A central role for DNA replication forks in checkpoint activation and response. Mol Cell. 2003;11:1323–1336. [PubMed]
  • Smith S, Hwang JY, Banerjee S, Majeed A, Gupta A, et al. Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 2004;101:9039–9044. [PubMed]
  • Myung K, Datta A, Chen C, Kolodner RD. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, suppresses genome instability and homeologous recombination. Nat Genet. 2001;27:113–116. [PubMed]
  • Iyer LM, Koonin EV, Aravind L. Novel predicted peptidases with a potential role in the ubiquitin signaling pathway. Cell Cycle. 2004;3:1440–1450. [PubMed]
  • O'Neill BM, Hanway D, Winzeler EA, Romesberg FE. Coordinated functions of WSS1, PSY2 and TOF1 in the DNA damage response. Nucleic Acids Res. 2004;32:6519–6530. [PMC free article] [PubMed]
  • Morishita T, Tsutsui Y, Iwasaki H, Shinagawa H. The Schizosaccharomyces pombe rad60 gene is essential for repairing double-strand DNA breaks spontaneously occurring during replication and induced by DNA-damaging agents. Mol Cell Biol. 2002;22:3537–3548. [PMC free article] [PubMed]
  • Komatsu S, Yanaka N, Matsubara K, Kato N. Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta. 2003;1647:127–130. [PubMed]
  • Huang S. Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer. 2002;2:469–476. [PubMed]
  • Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444:633–637. [PubMed]
  • Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature. 2006;444:638–642. [PubMed]
  • Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005;434:907–913. [PubMed]
  • Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–870. [PubMed]
  • Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 2007;21:43–48. [PubMed]
  • Goldstein AL, Pan X, McCusker JH. Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae. Yeast. 1999;15:507–511. [PubMed]
  • Sweeney FD, Yang F, Chi A, Shabanowitz J, Hunt DF, et al. Saccharomyces cerevisiae Rad9 Acts as a Mec1 Adaptor to Allow Rad53 Activation. Curr Biol. 2005;15:1364–1375. [PubMed]
  • Cabelof DC, Nakamura J, Heydari AR. A sensitive biochemical assay for the detection of uracil. Environ Mol Mutagen. 2006;47:31–37. [PubMed]
  • Hoffman CS, Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene. 1987;57:267–272. [PubMed]
  • Guillemette B, Bataille AR, Gevry N, Adam M, Blanchette M, et al. Variant histone H2A.Z is globally localized to the promoters of inactive yeast genes and regulates nucleosome positioning. PLoS Biol. 2005. e384. doi: 10.1371/journal.pbio.0030384. [PMC free article] [PubMed]
  • Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, et al. Genome-wide location and function of DNA binding proteins. Science. 2000;290:2306–2309. [PubMed]
  • Hokamp K, Roche FM, Acab M, Rousseau ME, Kuo B, et al. ArrayPipe: A flexible processing pipeline for microarray data. Nucleic Acids Res. 2004;32:W457–459. [PMC free article] [PubMed]
  • Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. The human genome browser at UCSC. Genome Res. 2002;12:996–1006. [PubMed]
Articles from PLoS Genetics are provided here courtesy of
Public Library of Science